Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-909-5 | CAS number: 128-80-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Justification for type of information:
- Data is from experimental report
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 005
- Report date:
- 2005
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Qualifier:
- according to guideline
- Guideline:
- other: Commision Directive 2004/73/EC, B.42: Skin Sensitization: Local Lymph Node Assay, 29 April 2001.
- Principles of method if other than guideline:
- The purpose of the Local Lymph Node Assay was to identify the contact allergenic potential of the test chemical when administered to the dorsum of both ear lobes of mice.
- GLP compliance:
- yes
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- 1,4-bis(p-tolylamino)anthraquinone
- EC Number:
- 204-909-5
- EC Name:
- 1,4-bis(p-tolylamino)anthraquinone
- Cas Number:
- 128-80-3
- Molecular formula:
- C28H22N2O2
- IUPAC Name:
- 1,4-bis[(4-methylphenyl)amino]-9,10-anthraquinone
- Test material form:
- solid
- Details on test material:
- - Name of test material (IUPAC name): 1,4-Bis(p-tolylamino)anthraquinone
- Common name: C.I. Solvent Green 3
- Molecular formula: C28H22N2O2
- Molecular weight: 418.4938 g/mol
- Smiles notation: c12c(c(Nc3ccc(cc3)C)ccc1Nc1ccc(cc1)C)C(=O)c1c(C2=O)cccc1
- InChl: 1S/C28H22N2O2/c1-17-7-11-19(12-8-17)29-23-15-16-24(30-20-13-9-18(2)10-14-20)26-25(23)27(31)21-5-3-4-6-22(21)28(26)32/h3-16,29-30H,1-2H3
- Substance type: Organic
- Physical State: Solid
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- CBA
- Remarks:
- CBA/CaOlaHsd
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Harlan Netherlands; B.V. Postbus 6174; NL - 5960 AD Horst / The Netherlands
- Females nulliparous and non-pregnant: yes
- Microbiological status of animals, when known: No data
- Age at study initiation: 8 - 12 weeks
- Weight at study initiation: 16 g - 24 g
- Identification: Each cage by unique cage card.
- Housing: Individual in Makrolon type-2 cages with standard softwood bedding ("Lignocel", Schill AG,CH-4132 Muttenz).
- Diet (e.g. ad libitum): Pelleted standard Kliba 3433, batch no. 92/04 mouse maintenance diet (Provimi Kliba AG, CH-4303 Kaiseraugst) available ad libitum.
- Water (e.g. ad libitum): Community tap water from Itingen, available ad libitum.
- Acclimation period: 6 days.
- Indication of any skin lesions: No data
- Acclimation period: 6 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 3 degC
- Humidity (%): 30 - 70 %
- Air changes (per hr): 10 - 15 air changes per hour.
- Photoperiod (hrs dark / hrs light): 12 hour fluorescent light / 12 hour dark cycle with at least 8 hours music during the light period.
- IN-LIFE DATES: From:09-FEB-2005 To:23-FEB-2005
Study design: in vivo (LLNA)
- Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- 1 (Control Group)
Group 2 - 2.5 % (w/v)
Group 3 - 5 % (w/v)
Group 4 - 10 % (w/v) - No. of animals per dose:
- 1 (Control Group) - 4 animals
Group 2 - 4 animals
Group 3 - 4 animals
Group 4 - 4 animals - Details on study design:
- PRE-TEST
In a non-GLP solubility pre-test, the test item was tested in different vehicles: acetone/olive oil, (4/1, v/v), dimethylsulfoxide (DMSO) and ehanol/water (7/3, v/v).A suitable vehicle (acetone/olive oil, (4/1, v/v)) was selected and used in the main test.
In a non-GLP animal pre-test in two mice, the test item was tested at four different concentrations: 1 %,2.5 %, 5 % and 10 % (w/v) , on one ear each.
24 hours after a single topical application, the pre-test results determined that 10 % (w/v) was the highest technically applicable concentration while avoiding systemic toxicity and excessive local irritation in the chosen vehicle.
TREATMENT PROCEDURES
TOPICAL APPLICATION
Each test group of mice was treated by topical (epidermal) application to the dorsal surface of each ear lobe (Ieft and right) with different test item concentrations of 2.5 %, 5 % and 10 % (w/v) in acetone/olive oil (4/1 (v/v). The application volume, 25 μl, was spread over the entire dorsal surface (Ø - 8 mm) of each ear lobe once daily for three consecutive days. A further group of mice was treated with an equivalent volume of the relevant vehicle alone (control animals). A hair dryer was passed briefly over the ear's surface to prevent the loss of any of the test item applied.
ADMINISTRATION OF 3H-METHYL THYMIDINE*
3H-methyl thymidine (3HTdR) was purchased from Amersham International (Amersham product code no. TRA 310; specific activity, 2 Ci/mmol; concentration,1 mCi /ml).Five days after the first topical application, all mice were administered with 250 μI of 76.13 μCi/ml 3HTdR (equal to 19.0 μCi 3HTdR) by intravenous injection via a tail vein.
DETERMINATION OF INCORPORATED 3HTDR*
Approximately five hours after treatment with 3HTdR all mice were euthanized by inhalation of CO2 (dry ice).
The draining Iymph nodes were rapidly excised and pooled for each experimental group (8 nodes per group). Single cell suspensions (phosphate buffered saline) of pooled Iymph node cells were prepared by gentle mechanical disaggregation through stainless steel gauze (200 μm mesh size). After washing two
times with phosphate buffered saline (approx. 10 ml) the Iymph node cells were resuspended in 5 % trichloroacetic acid (approx. 3 ml) and incubated at approximately +4 °C for at least 18 hours for precipitation of macromolecules.The precipitates were then resuspended in 5 % trichloroacetic acid (1 ml) and transferred to glass scintillation vials with 10 ml of 'Irga-Safe Plus' scintillation liquid and thoroughly mixed.The level of 3HTdR incorporation was then measured on a ß-scintillation counter. Similarly, background 3HTdR levels were also measured in two 1 ml-aliquots of 5 % trichloroacetic acid.The ß-scintillation counter expresses 3HTdR incorporation as the number of radioactive disintegrations per minute (DPM). - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- The mean values and standard deviations were calculated in the body weight tables.
Results and discussion
- Positive control results:
- Positive control results
CALCULATION AND RESULTS OF INDIVIDUAL DATA
The proliferative capacity of pooled Iymph node cells was determined by the incorporation of 3H-methylthymidine measured on a ß-scintillation counter.
Test item concentration % (w/v) S.I.
Group 2 5* 2.4*
Group 3 10• 3.6 •
Group 4 25 11.2
EC3 = 7.5 % (w/v)
A clear dose-response relationship was observed.
• This value was used in calculation of EC3.
VIABILITY / MORTALITY
No deaths occurred during the study period.
CLINICAL SIGNS
No clinical signs were observed in any animals of the control group.On the second application day,a slight ear swelling was observed at both dosing sites in all mice of group 4(25%), persisting for the remainder of the in-life phase of the study.One day after the third local application, a slight ear swelling was observed at both dosing sites in all mice of Group2 (5%) and Group3 (10%), persisting for the remainder of the in-life phase of the study.
BODY WEIGHTS
The body wejght of the animals, recorded prior to the 1st application and prior to necropsy,was within the range commonly recorded for animals of this strain and age.
CONCLUSION
A test item is regarded as a sensitizer in the LLNA if the exposure to one or more test concentrations resulted in 3-fold or greater increase in incorporation of 3HTdR compared with concurrent controls, as indicated by the STIMULATION INDEX (S.I.).
In this study STIMULATION INDICES of 2.4, 3.6 and 11.2 were determined with the test item at concentrations of 5 %, 10 % and 25 % (w/v) , respectively, in acetone:olive oil, 4:1 (vIv).
ALPHA-HEXYLCINNAMALDEHYDE was therefore found to be a skin sensitizer and an EC3 value of 7.5 % (w/v) was derived.
In vivo (LLNA)
Resultsopen allclose all
- Key result
- Parameter:
- SI
- Value:
- 1.8
- Test group / Remarks:
- Group2: 2.5 % (w/v) in acetone/olive oil (4/1, v/v).
- Remarks on result:
- other: not sensitizing
- Key result
- Parameter:
- SI
- Value:
- 0.8
- Test group / Remarks:
- Group3: 5 % (w/v) in acetone/olive oil (4/1, v/v).
- Remarks on result:
- other: not sensitizing
- Key result
- Parameter:
- SI
- Value:
- 1.2
- Test group / Remarks:
- Group4: 10 % (w/v) in acetone/olive oil (4/1, v/v).
- Remarks on result:
- other: not sensitizing
- Cellular proliferation data / Observations:
- CELLULAR PROLIFERATION DATA
The proliferative capacity of pooled Iymph node cells was determined by the incorporation of 3H-methylthymidine measured on a ß-scintillation counter.
Test item concentration% (w/v) S.l.
Group 2 2.5 1.8
Group 3 5 0.8
Group 4 10 1.2
No dose-response relationship was observed.
Calculation of the EC3 value was not done because no test concentrations produced a STIMULATION INDEX (S.I.) of 3 or higher.
EC3 CALCULATION
Calculation of the EC3 value was not done because no test concentrations produced a STIMULATION INDEX (S.I.) of 3 or higher.
CLINICAL OBSERVATIONS:
No clinical signs were observed in any animals of the control group. After the first application, both ears of all test item groups of mice (Groups 2-4) showed black at dosing sites, persisting for the remainder of the in-life phase of the study.
BODY WEIGHTS
The body weight of the animals, recorded prior to the first application and prior to neroscopy,was within the range commonly recorded for animals of the strain and age.
VIABILITY / MORTALITY
No deaths occurred during the study period.
Any other information on results incl. tables
Positive Control Study
SUMMARY
In order to study a possible contact allergenic potential of ALPHAHEXYLCINNAMALDEHYDE,three groups each of four female mice were treated daily with the test item at concentrations of 5 %, 10 % and 25 %(w/v) in acetone:olive oil, 4: 1 (v/v) by topical application to the dorsum of each ear lobe (Ieft and right) for three consecutive days.
A control group of four mice was treated with the vehicle (acetone:olive oil, 4:1 (v/v)) only.
Five days after the first topical application the mice were injected intravenously into a tail vein with radio-Iabelled thymidine (3H-methyl thymidine). Approximately five hours after intravenous injection, the mice were sacrificed, the draining auricular lymph nodes excised and pooled per group. Single cell suspensions of lymph node cells were prepared from pooled lymph nodes which were subsequently washed and incubated with trichloroacetic acid overnight. The proliferative capacity of pooled Iymph node cells was determined by the incorporation of 3H-methyl thymidine measured in a ß-scintillation counter.
All treated animals survived the scheduled study period.
No clinical signs were observed in any animals of the control group.On the second application day,a slight ear swelling was observed at both dosing sites in all mice of group 4 (25%), persisting for the remainder of the in-life phase of the study.One day after the third local application, a slight ear swelling was observed at both dosing sites in all mice of Group2 (5%) and Group3 (10%), persisting for the remainder of the in-life phase of the study.
The results obtained (STIMULATION INDEX (S.I.)) are reported in the following table. The estimated concentration of test item required to produce a S.I. of 3 is referred to as the EC3 value.
Test item concentration % (w/v) |
S.I. |
|
Group 2 |
5* |
2.4* |
Group 3 |
10* |
3.6* |
Group 4 |
25 |
11.2 |
EC3 = 7.5 % (w/v) |
||
A clear dose-response relation was observed. • This value was used in calculation of EC3. |
Applicant's summary and conclusion
- Interpretation of results:
- other: Not sensitising
- Conclusions:
- A test item is regarded as a sensitizer in the LLNA if the exposure to one or more test concentrations resulted in 3-fold or greater increase in incorporation of 3HTdR compared with concurrent controls, as indicated by the STIMULATION INDEX (S.I.).
In this study STIMULATION INDICES of 1.8, 0.8 and 1.2 were determined with the test item at concentrations of 2.5 %, 5 % and 10 % (w/v) , respectively, in acetone/olive oil (4/1 (v/v).
The test chemical was therefore considered to be a non-sensitizer when tested at up to the highest applicable concentration of 10 % (w/v) in acetone/olive oil (4/1 (v/v). - Executive summary:
The purpose of the Local Lymph Node Assay was to identify the contact allergenic potential of the test chemical when administered to the dorsum of both ear lobes of mice. The study was performed according to OECD 429 and Commision Directive 2004/73/EC, B.42: Skin Sensitization: Local Lymph Node Assay, 29 April 2001 Guidelines.
In order to study a possible contact allergenic potential of the test chemical, three groups each of four female CBA/CaOlaHsd mice were treated daily with the test item at concentrations of 2.5 %, 5% and 10% (w/v) in acetone/olive oil (4/1, v/v) by topical application to the dorsum of each ear lobe (left and right) for three consecutive days. 10 % was the highest technically applicable concentration in the vehicle. A control group of four mice was treated with the vehicle (acetone/olive oil (4/1, v/v)) only. Five days after the first topical application the mice were injected intravenously into a tail vein with radio-labelled thymidine (3H-methyl thymidine). Approximately five hours after intravenous injection, the mice were sacrificed, the draining auricular lymph nodes excised and pooled per group. Single cell suspensions of lymph node cells were prepared from pooled lymph nodes which were subsequently washed and incubated with trichloroacetic acid overnight. The proliferative capacity of pooled lymph node cells was determined by the incorporation of 3H-methyl thymidine measured in a ß-scintillation counter. All treated animals survived the scheduled study period. No clinical signs were observed in any animals of the control group. After the first application, both ears of all test item groups of mice (Groups 2-4) showed black at dosing sites, persisting for the remainder of the in-life phase of the study. The results obtained (STIMULATION INDEX (S.I.)) are reported in the following table. Calculation of the EC 3 value was not done because no test concentrations produced a STIMULATION INDEX (S.I.) of 3 or higher.
In this study STIMULATION INDICES of 1.8, 0.8 and 1.2 were determined with the test item at concentrations of 2.5 %, 5 % and 10 % (w/v) , respectively, in acetone/olive oil (4/1 (v/v).
The test chemical was therefore found to be a non-sensitizer when tested at up to the highest applicable concentration of 10 % (w/v) in acetone/olive oil (4/1 (v/v).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.